Serious liver injury being observed in patients without cirrhosis taking Ocaliva (obeticholic aci...

  Рет қаралды 509

U.S. Food and Drug Administration

U.S. Food and Drug Administration

Күн бұрын

Serious liver injury being observed in patients without cirrhosis taking Ocaliva (obeticholic acid) to treat primary biliary cholangitis

Пікірлер
National Drug Code (NDC) for Healthcare Providers
41:59
U.S. Food and Drug Administration
Рет қаралды 1,2 М.
Маусымашар-2023 / Гала-концерт / АТУ қоштасу
1:27:35
Jaidarman OFFICIAL / JCI
Рет қаралды 390 М.
요즘유행 찍는법
0:34
오마이비키 OMV
Рет қаралды 12 МЛН
FDA Clinical Investigator Training Course (CITC) 2024 - Day One - Session Two
1:42:25
U.S. Food and Drug Administration
Рет қаралды 1,9 М.
CDER BIMO: Electronic Submission Requirements for New Drug and Biologic Licensing Applications
17:02
FDA Clinical Investigator Training Course (CITC) 2024 - Day One - Session One
2:14:51
U.S. Food and Drug Administration
Рет қаралды 1 М.
January 10, 2025 Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) Meeting
7:49:20
U.S. Food and Drug Administration
Рет қаралды 1,8 М.
MEDIA CALL: Front of Package Nutrition Labels - 1/14/2025
19:15
U.S. Food and Drug Administration
Рет қаралды 1 М.
VIRTUAL PRESS CONFERENCE: FDA’s Proposed Rule on Reducing Nicotine Levels - 1/15/2025
20:43
U.S. Food and Drug Administration
Рет қаралды 1,4 М.
FDA Clinical Investigator Training Course (CITC) 2024 - Day Two - Session Two
2:23:52
U.S. Food and Drug Administration
Рет қаралды 644
FDA Clinical Investigator Training Course (CITC) 2024 - Day Three - Session One
1:43:17
U.S. Food and Drug Administration
Рет қаралды 438